{"id":499106,"date":"2021-05-26T16:04:24","date_gmt":"2021-05-26T20:04:24","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/celldex-to-present-at-the-jefferies-2021-virtual-healthcare-conference\/"},"modified":"2021-05-26T16:04:24","modified_gmt":"2021-05-26T20:04:24","slug":"celldex-to-present-at-the-jefferies-2021-virtual-healthcare-conference","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/celldex-to-present-at-the-jefferies-2021-virtual-healthcare-conference\/","title":{"rendered":"Celldex to Present at the Jefferies 2021 Virtual Healthcare Conference"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"left\">HAMPTON, N.J., May  26, 2021  (GLOBE NEWSWIRE) &#8212; Celldex Therapeutics, Inc. (NASDAQ:CLDX) today announced that senior management will participate in a fireside chat at the Jefferies 2021 Virtual Healthcare Conference on Wednesday, June 2, 2021 at 1:30 p.m. ET.<\/p>\n<p>A webcast of the presentation will be available on the <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=XJm21dMUbqOFiKlg4qgvstq6hc-pI6IZC64Tgf2qTGMroZl7AxfUagBqXfUFt5c2YJHce_hZCqfEpTFVULrKC0N2Q-wwljQd83W521D6GC_FkqjsYO_ReMMFYHn5PbGqFlTxI_UwZCj8LmViflptxA==\" rel=\"nofollow noopener\" target=\"_blank\">&#8220;Events &amp; Presentations&#8221;<\/a> page of the <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=-doEgma0h9SmQPWO-ocrqhDTd15RfF4WMKMCE-XflGfeh6Ikb8ddATR31eWpehswXcyA5UhRRDTBvj_ZT1EAJEwdY6NC66ieB5O9TdWC140=\" rel=\"nofollow noopener\" target=\"_blank\">&#8220;Investors &amp; Media<\/a>&#8221; section of the Celldex website. A replay will be available for 30 days following the event.<\/p>\n<p>\n        <strong>About Celldex Therapeutics, Inc.<\/strong><br \/>\n        <br \/>Celldex is a clinical stage biotechnology company dedicated to developing monoclonal and bispecific antibodies that address devastating diseases for which available treatments are inadequate. Our pipeline includes antibody-based therapeutics which have the ability to engage the human immune system and\/or directly affect critical pathways to improve the lives of patients with inflammatory diseases and many forms of cancer. Visit <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=1QSuz8RhUelHixtS_vmCNqRt1AVvEVWbk6ofcVZjSzXhbqkUPRou-3cuogK27NUQ85E0ZDULyn3f7Rag4q-vvg==\" rel=\"nofollow noopener\" target=\"_blank\">www.celldex.com<\/a>.<\/p>\n<p>\n        <strong>Company Contact<\/strong><br \/>\n        <br \/>Sarah Cavanaugh<br \/>Senior Vice President, Corporate Affairs &amp; Administration<br \/>(508) 864-8337<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=qPHPBDmy5iVNel9UotVGb8rTGTFhWB1taF4QApL0t8tb58SgxJXghX8C1u9T0ICQwPeZPe-VHYL1b86VQvDdyJ-1YuTbJ_hiRMxmO90qbqw=\" rel=\"nofollow noopener\" target=\"_blank\">scavanaugh@celldex.com<\/a><\/p>\n<p>Patrick Till<br \/>Senior Director, Investor Relations &amp; Corporate Communications<br \/>(484) 788-8560<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=kL3BRG62Bp46E5F4vZsAOZQvyGfy9RiCRytSAytEbzh8R6pHLiJb2jZqGXo20Ujctp0tDOF7xKvlJNsPplcAng==\" rel=\"nofollow noopener\" target=\"_blank\">ptill@celldex.com<\/a><\/p>\n<p>      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI0MzY4NSM0MjAzNTEwIzIwMDUxODk=\" width=\"1\" height=\"1\" \/><br \/>\n      <br \/>\n      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/ml.globenewswire.com\/release\/track\/064c6e59-a923-4874-819e-0f3a248dcb1a\" width=\"1\" height=\"1\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>HAMPTON, N.J., May 26, 2021 (GLOBE NEWSWIRE) &#8212; Celldex Therapeutics, Inc. (NASDAQ:CLDX) today announced that senior management will participate in a fireside chat at the Jefferies 2021 Virtual Healthcare Conference on Wednesday, June 2, 2021 at 1:30 p.m. ET. A webcast of the presentation will be available on the &#8220;Events &amp; Presentations&#8221; page of the &#8220;Investors &amp; Media&#8221; section of the Celldex website. A replay will be available for 30 days following the event. About Celldex Therapeutics, Inc. Celldex is a clinical stage biotechnology company dedicated to developing monoclonal and bispecific antibodies that address devastating diseases for which available treatments are inadequate. Our pipeline includes antibody-based therapeutics which have the ability to engage the human immune system and\/or directly affect &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/celldex-to-present-at-the-jefferies-2021-virtual-healthcare-conference\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Celldex to Present at the Jefferies 2021 Virtual Healthcare Conference&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-499106","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Celldex to Present at the Jefferies 2021 Virtual Healthcare Conference - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/celldex-to-present-at-the-jefferies-2021-virtual-healthcare-conference\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Celldex to Present at the Jefferies 2021 Virtual Healthcare Conference - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"HAMPTON, N.J., May 26, 2021 (GLOBE NEWSWIRE) &#8212; Celldex Therapeutics, Inc. (NASDAQ:CLDX) today announced that senior management will participate in a fireside chat at the Jefferies 2021 Virtual Healthcare Conference on Wednesday, June 2, 2021 at 1:30 p.m. ET. A webcast of the presentation will be available on the &#8220;Events &amp; Presentations&#8221; page of the &#8220;Investors &amp; Media&#8221; section of the Celldex website. A replay will be available for 30 days following the event. About Celldex Therapeutics, Inc. Celldex is a clinical stage biotechnology company dedicated to developing monoclonal and bispecific antibodies that address devastating diseases for which available treatments are inadequate. Our pipeline includes antibody-based therapeutics which have the ability to engage the human immune system and\/or directly affect &hellip; Continue reading &quot;Celldex to Present at the Jefferies 2021 Virtual Healthcare Conference&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/celldex-to-present-at-the-jefferies-2021-virtual-healthcare-conference\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-05-26T20:04:24+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI0MzY4NSM0MjAzNTEwIzIwMDUxODk=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/celldex-to-present-at-the-jefferies-2021-virtual-healthcare-conference\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/celldex-to-present-at-the-jefferies-2021-virtual-healthcare-conference\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Celldex to Present at the Jefferies 2021 Virtual Healthcare Conference\",\"datePublished\":\"2021-05-26T20:04:24+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/celldex-to-present-at-the-jefferies-2021-virtual-healthcare-conference\\\/\"},\"wordCount\":172,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/celldex-to-present-at-the-jefferies-2021-virtual-healthcare-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODI0MzY4NSM0MjAzNTEwIzIwMDUxODk=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/celldex-to-present-at-the-jefferies-2021-virtual-healthcare-conference\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/celldex-to-present-at-the-jefferies-2021-virtual-healthcare-conference\\\/\",\"name\":\"Celldex to Present at the Jefferies 2021 Virtual Healthcare Conference - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/celldex-to-present-at-the-jefferies-2021-virtual-healthcare-conference\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/celldex-to-present-at-the-jefferies-2021-virtual-healthcare-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODI0MzY4NSM0MjAzNTEwIzIwMDUxODk=\",\"datePublished\":\"2021-05-26T20:04:24+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/celldex-to-present-at-the-jefferies-2021-virtual-healthcare-conference\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/celldex-to-present-at-the-jefferies-2021-virtual-healthcare-conference\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/celldex-to-present-at-the-jefferies-2021-virtual-healthcare-conference\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODI0MzY4NSM0MjAzNTEwIzIwMDUxODk=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODI0MzY4NSM0MjAzNTEwIzIwMDUxODk=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/celldex-to-present-at-the-jefferies-2021-virtual-healthcare-conference\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Celldex to Present at the Jefferies 2021 Virtual Healthcare Conference\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Celldex to Present at the Jefferies 2021 Virtual Healthcare Conference - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/celldex-to-present-at-the-jefferies-2021-virtual-healthcare-conference\/","og_locale":"en_US","og_type":"article","og_title":"Celldex to Present at the Jefferies 2021 Virtual Healthcare Conference - Market Newsdesk","og_description":"HAMPTON, N.J., May 26, 2021 (GLOBE NEWSWIRE) &#8212; Celldex Therapeutics, Inc. (NASDAQ:CLDX) today announced that senior management will participate in a fireside chat at the Jefferies 2021 Virtual Healthcare Conference on Wednesday, June 2, 2021 at 1:30 p.m. ET. A webcast of the presentation will be available on the &#8220;Events &amp; Presentations&#8221; page of the &#8220;Investors &amp; Media&#8221; section of the Celldex website. A replay will be available for 30 days following the event. About Celldex Therapeutics, Inc. Celldex is a clinical stage biotechnology company dedicated to developing monoclonal and bispecific antibodies that address devastating diseases for which available treatments are inadequate. Our pipeline includes antibody-based therapeutics which have the ability to engage the human immune system and\/or directly affect &hellip; Continue reading \"Celldex to Present at the Jefferies 2021 Virtual Healthcare Conference\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/celldex-to-present-at-the-jefferies-2021-virtual-healthcare-conference\/","og_site_name":"Market Newsdesk","article_published_time":"2021-05-26T20:04:24+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI0MzY4NSM0MjAzNTEwIzIwMDUxODk=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/celldex-to-present-at-the-jefferies-2021-virtual-healthcare-conference\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/celldex-to-present-at-the-jefferies-2021-virtual-healthcare-conference\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Celldex to Present at the Jefferies 2021 Virtual Healthcare Conference","datePublished":"2021-05-26T20:04:24+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/celldex-to-present-at-the-jefferies-2021-virtual-healthcare-conference\/"},"wordCount":172,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/celldex-to-present-at-the-jefferies-2021-virtual-healthcare-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI0MzY4NSM0MjAzNTEwIzIwMDUxODk=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/celldex-to-present-at-the-jefferies-2021-virtual-healthcare-conference\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/celldex-to-present-at-the-jefferies-2021-virtual-healthcare-conference\/","name":"Celldex to Present at the Jefferies 2021 Virtual Healthcare Conference - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/celldex-to-present-at-the-jefferies-2021-virtual-healthcare-conference\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/celldex-to-present-at-the-jefferies-2021-virtual-healthcare-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI0MzY4NSM0MjAzNTEwIzIwMDUxODk=","datePublished":"2021-05-26T20:04:24+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/celldex-to-present-at-the-jefferies-2021-virtual-healthcare-conference\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/celldex-to-present-at-the-jefferies-2021-virtual-healthcare-conference\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/celldex-to-present-at-the-jefferies-2021-virtual-healthcare-conference\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI0MzY4NSM0MjAzNTEwIzIwMDUxODk=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI0MzY4NSM0MjAzNTEwIzIwMDUxODk="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/celldex-to-present-at-the-jefferies-2021-virtual-healthcare-conference\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Celldex to Present at the Jefferies 2021 Virtual Healthcare Conference"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/499106","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=499106"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/499106\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=499106"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=499106"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=499106"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}